Omada Health Reports Strong Preliminary Q4 and FY 2025 Revenue and Member Growth
summarizeSummary
Omada Health reported preliminary Q4 and full-year 2025 revenue growth exceeding 50% year-over-year, alongside a substantial increase in total members, signaling strong business performance.
check_boxKey Events
-
Strong Q4 2025 Revenue Growth
Preliminary unaudited revenue for Q4 2025 is projected between $72 million and $74 million, representing a 50% to 54% increase year-over-year.
-
Robust Full-Year 2025 Revenue
Preliminary full-year 2025 revenue is expected to be between $256 million and $258 million, reflecting 51% to 52% growth compared to 2024.
-
Significant Member Growth
Total members reached approximately 886,000 as of December 31, 2025, marking a 55% increase from the previous year.
-
Strategic Initiatives Highlighted
CEO Sean Duffy noted advancements in GLP-1 care offerings and the integration of AI across the platform to drive member outcomes.
auto_awesomeAnalysis
Omada Health announced robust preliminary financial results for the fourth quarter and full-year 2025, showcasing significant year-over-year revenue and member growth. These unaudited figures, released ahead of the J.P. Morgan Healthcare Conference, indicate strong business momentum and increasing adoption of its virtual care model. The company's strategic focus on enhancing GLP-1 care offerings and leveraging AI positions it for continued growth in the chronic care market. Investors should monitor the final audited results in March for confirmation of these positive trends.
At the time of this filing, OMDA was trading at $15.50 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $952M. The 52-week trading range was $14.14 to $28.40. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.